<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://polariswire.com/discover/nasa-artemis-lander-realignment-2028/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-24T00:15:29.445741+00:00</news:publication_date><news:title>NASA Realigns Artemis Landers, Targets Crewed Moon Landing in 2028</news:title></news:news></url><url><loc>https://polariswire.com/discover/nasa-swift-mission-ends-archive/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-24T00:15:22.381127+00:00</news:publication_date><news:title>NASA’s Swift Mission Ends After 22 Years, Leaves Extensive Archive</news:title></news:news></url><url><loc>https://polariswire.com/discover/openai-frontier-training-offline/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-24T00:15:14.205017+00:00</news:publication_date><news:title>OpenAI moves frontier training offline after model internet breach</news:title></news:news></url><url><loc>https://polariswire.com/discover/intel-fcc-robotics-waiver/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T20:01:38.702145+00:00</news:publication_date><news:title>FCC Grants Intel One-Year Waiver on Foreign-Made Fab Robots</news:title></news:news></url><url><loc>https://polariswire.com/discover/ancient-viral-dna-chimp-brain-gene/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T20:00:02.895890+00:00</news:publication_date><news:title>Ancient Viral DNA in Chimp Genome Tied to Brain Gene Control</news:title></news:news></url><url><loc>https://polariswire.com/discover/intismeran-melanoma-phase-iii-42-percent/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T15:14:22.081385+00:00</news:publication_date><news:title>Personalized mRNA vaccine cuts melanoma recurrence risk by 42% in phase III trial</news:title></news:news></url><url><loc>https://polariswire.com/discover/personalised-mrna-melanoma-vaccine-trial/</loc><news:news><news:publication><news:name>PolarisWire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-23T09:39:10.498574+00:00</news:publication_date><news:title>Personalised mRNA cancer vaccine cuts melanoma recurrence risk in trial</news:title></news:news></url></urlset>